ChroMedX is very pleased to announce that following an extensive vetting process the Company has collaborated with manufacturing and dispensing specialists BioDot Inc. of Irvine, California to custom modify a dispensing platform to produce the sensors in-house, greatly accelerating the manufacturing, development and testing of the biosensor component.
“This is a major turning point for HemoPalm development and the biosensor is now on the critical path. Our results with McMaster were positive but the manufacturing of the sensors greatly slowed the process. Our collaboration with BioDot has put us on the fast-track and the sensors developed with them have exceeded our expectations.” said Ash Kaushal, President & CEO, ChroMedX Corp.
Read the full press release here: https://transmedia-industries-x6et.squarespace.com/chromedx-inhouse-biosensor-manufacturing-for-expedited-testing-and-refinement